President Trump signed an executive order on Thursday that launches a pilot program authorizing Medicare to cover cannabis products for seniors. The executive order reclassifies marijuana as a Schedule III drug under the U.S. Drug Enforcement Agency in addition to authorizing the Medicare pilot. Medicare will specifically only cover cannabidiol products, or CBD. Coverage will start “as early as April of next year at no charge, if their doctors recommend them,” CMS administrator Mehmet Oz said at the signing.
Read the full article: Trump Green-Lights These “No Charge” Marijuana Products for Medicare Enrollees //
Source: https://www.axios.com/2025/12/18/schedule-3-drugs-trump-weed-medicare